MEDFAR buys AlloMia to put AI voice agents at the clinic front desk
What's the deal? MEDFAR, the Canadian healthcare technology company behind the electronic medical record (EMR) MYLE, has acquired AlloMiaDealroom has a profile for this one. Try Dealroom →, a developer of AI voice agents that handle patient calls for a clinic's front desk. Terms were not disclosed. It is MEDFAR's second AI acquisition in under two years.
Why now? In most clinics, the phone remains one of the busiest points of contact between patients and staff. Clinics can field thousands of calls a week, leading to long hold times, missed calls, no-shows, and frustrated patients.
What's the endgame? AlloMia's voice agent answers calls instantly, handles requests, books appointments directly into the clinic's schedule, and routes callers to the right resource, 24/7. The goal is to free staff to focus on care rather than administrative work.
The acquisition adds a fourth AI capability to MYLE, joining AI Scribe, which captures clinical conversations into documentation; AI Form-Filling, which completes clinical forms; and AI Indexing, which organises incoming clinical documents. MEDFAR embeds each tool in the system teams already use rather than as a separate product.
The results so far: AlloMia has been piloted with a group of MYLE clinics since March 2026. In the most recently onboarded clinics, about 50% of calls are now handled start to finish by the agent, with no transfer to reception.
"Healthcare teams need more than a place to store information. They need intelligent technology that can understand what is happening, take action and help them move faster," said Elias Farah, president of MEDFAR.
AlloMia co-founder and chief executive officer Sitech Lim framed the rationale around staff burden. "Nobody chooses a career in healthcare to spend their day answering a ringing phone," he said. "We built AlloMia to take away some of that administrative burden."
The signal: MEDFAR is positioning MYLE as a "system of intelligence" rather than a passive record, stacking AI across the full patient journey from the first phone call to the exam room. The deal reflects a broader push among health-tech firms to buy, not build, AI capabilities and fold them into existing workflows.
Read more: newswire.ca
Image credit: Allomia